Cargando…
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Chronic spontaneous urticaria (CSU) is defined as the spontaneous development of itchy hives and/or angioedema due to known or unknown causes that last for at least 6 weeks. At any given time, CSU is believed to affect 0.5–1% of the global population. Omalizumab (a recombinant, humanized anti-immuno...
Autores principales: | Metz, Martin, Vadasz, Zahava, Kocatürk, Emek, Giménez-Arnau, Ana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351799/ https://www.ncbi.nlm.nih.gov/pubmed/32418171 http://dx.doi.org/10.1007/s12016-020-08794-6 |
Ejemplares similares
-
Updosing of Nonsedating Anti-histamines in Recalcitrant Chronic Urticaria
por: Godse, Kiran, et al.
Publicado: (2016) -
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
por: Staevska, Maria T
Publicado: (2016) -
The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A
por: Lobna, Matanis, et al.
Publicado: (2021) -
Looking forward to new targeted treatments for chronic spontaneous urticaria
por: Kocatürk, Emek, et al.
Publicado: (2017) -
Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria
por: Kocatürk, Emek, et al.
Publicado: (2017)